Turmeric rhizome has been used for centuries to combat inflammation, including joint inflammation in arthritis. However, scientific evidence of efficacy and mechanism of action and a systematic evaluation of the biological activity of turmeric components for the treatment of inflammation have been lacking. This review will summarize the results of recently published studies that we have conducted to address each of these specific areas of inquiry using an animal model of rheumatoid arthritis.
SwansonCA. (2004) Suggested guidelines for articles about botanical dietary supplements. American Journal of Clinical Nutrition, 75, 8–10.
2.
DeodharSD, SethiR, SrimalRC. (1980) Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian Journal of Medical Research, 71, 632–634.
3.
BanerjeeM, TripathiLM, SrivastavaVM, PuriA, ShuklaR. (2003) Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacology and Immunotoxicology, 25, 213–224.
4.
JoeB, RaoUJ, LokeshBR. (1997) Presence of an acidic glycoprotein in the serum of arthritic rats: modulation by capsaicin and curcumin. Molecular and Cellular Biochemistry, 169, 125–134.
5.
MukhopadhyayA, BasuN, GhatakN, GujralPK. (1982) Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents and Actions, 12, 508–515.
FunkJL, FryeJB, OyarzoJN, KuscuogluN, WilsonJ, McCaffreyG, StaffordG, ChenG, LantzRC, JoladSD, SólyomAM, KielaPR, TimmermannBN. (2006) Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis. Arthritis and Rheumatism, 3452–3464.
8.
FunkJL, ChenJ, DowneyKJ, DaveeS, StaffordG. (2003) Blockade of PTHrP prevents joint destruction and granuloma formation in streptococcal cell wall-induced arthritis. Arthritis and Rheumatism, 48, 1721–1731.
9.
GeratzJD, TidwellRR, SchwabJH, AnderleSK, PryzwanskyKB. (1990) Sequential events in the pathogenesis of SCW-induced arthritis and their modulation by bis(5-amidino-2-benzimidazolyl)methane. American Journal of Pathology, 136, 909–921.
10.
AllenJB, MaloneDG, WahlSM, CalandraGB, WilderRL. (1985) Role of the thymus in streptococcal cell wall-induced arthritis and hepatic granuloma formation. Comparative studies of pathology and cell wall distribution in athymic and euthymic rats. Journal of Clinical Investigation, 76, 1042–1056.
11.
ChoyEH, PanayiGS. (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. New England Journal of Medicine, 344, 907–916.
12.
AletahaD, WardMM. (2006) Duration of rheumatoid arthritis influences the degree of functional improvement in clinical trials. Annals of Rheumatic Diseases, 65, 227–233.
13.
RoshakAK, CallahanJF, BlakeSM. (2002) Small-molecule inhibitors of NF-kappaB for the treatment of inflammatory joint disease. Current Opinion in Pharmacology, 2, 316–321.
14.
PalombellaVJ, ConnerEM, FuselerJW, DestreeA, DavisJM, LarouxFS, WolfRE, HuangJ, BrandS, ElliottPJ, LazarusD, McCormakT, ParentL, SteinR, AdamsJ, GrishamMB. (1998) Role of the proteosome and NF-kB in SCW-induced polyarthritis. Proceedings of the National Academy of Science, 95, 15671–15676.
15.
WooleyPH, DutcherJ, WidmerMB, GillisS. (1993) Influence of a recombinant human soluble TNF receptor FC fusion protein on type II collagen-induced arthritis in mice. Journal of Immunology, 151, 6602–6607.
16.
FiresteinGS. (2004) NF-kappaB: Holy Grail for rheumatoid arthritis?Arthritis and Rheumatism, 50, 2381–2386.
17.
HofbauerLC, SchoppetM. (2004) Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. Journal of the American Medical Association, 292, 490–495.
18.
ClohisyJC, RoyBC, BiondoC, FrazierE, WillisD, TeitelbaumSL, Abu-AmerY. (2003) Direct inhibition of NF-κB blocks bone erosion associated with inflammatory arthritis. Journal of Immunology, 171, 5547–5553.
19.
GravalleseEM, GalsonDL, GoldringSR, AuronPE. (2001) The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption. Arthritis Research, 3, 6–12.
20.
AggarwalBB, KumarA, AggarwalMS, ShishodiaS. (2004) Curcumin derived from turmeric (Curcuma longa): a spice for all seasons. in Phytopharmaceuticals in Cancer Chemoprevention. BagchiD, PreusHG, (Ed). CRC Press: Boca Raton, FL, 349–387.
21.
JobinC, BradhamCA, RussoMP, JumaB, NarulaAS, BrennerDA, SartorRB. (1999) Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. Journal of Immunology, 163, 3474–3483.
22.
Grandjean-LaquerriereA, GangloffSC, Le NaourR, TrentesauxC, HornebeckW, GuenounouM. (2002) Relative contribution of NF-kappaB and AP-1 in the modulation by curcumin and pyrrolidine dithiocarbamate of the UVB-induced cytokine expression by keratinocytes. Cytokine, 18, 168–177.
23.
ZhangF, AltorkiNK, MestreJR, SubbaramaiahK, DannenbergAJ. (1999) Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis, 20, 445–451.
24.
DannenbergAMJr, RookGAW. (1994) Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immune responses – dual mechanisms that control bacillary multiplication. In Tuberculosis: Pathogenesis, Protection, and Control.BloomBR. (Ed), American Society for Microbiology, Washington, DC. 459–483.
25.
PerezRL, Rivera-MarreroCA, RomanJ. (2003) Pulmonary granulomatous inflammation: From sarcoidosis to tuberculosis. Seminars in Respiratory Infection, 18, 23–32.
26.
Chainani-WuN. (2003) Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa). Journal of Alternative and Complementary Medicine, 9, 161–168.
